Health-care companies fell, but not by as much as the broad market, amid a generally strong round of earnings from drugmakers. AbbVie shares rose after the pharmaceutical company reported ...
1hon MSN
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Super Bowl LIX is already proving to offer serious star power, with ad spots led by Chris Pratt, Eugene Levy, Michelle Rodriguez and even a When Harry Met Sally reunion with Meg Ryan and Billy Crystal ...
European shares closed at a record high on Friday (Jan 31), led by technology stocks, as earnings from companies such as ...
Novartis Ag (NYSE: NVS) Q4 2024 Earnings Call Jan 31, 2025, 8:00 a.m. ET ...
Aggressive treatment before ocular surgery helps avoid postoperative issues with visual quality in patients with dry eye ...
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...
CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and core operating income rising 29% in constant currency. For the full year, the company achieved a ...
Novartis chief executive says large pharma deals usually don't pay off. But the company remains interested in bolt-on ...
One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...
Ionis Pharmaceuticals (IONS) stock slips as Novartis (NVS) delays Phase 3 trial data for its cardiac therapy pelacarsen. Read ...
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback